Demo Sign up Log In

Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Total Current Assets

$52.97M

Quarterly · Period ending: Jun 30, 2026 · USD

LCTX Total Current Assets

Latest reported$52.97Mperiod endingJun 30, 2026

Latest reported$52.97Mperiod endingJun 30, 2026

LCTX Quarterly Current Assets ($5.20M → $52.97M)

Quarterly total current assets

High-resolution chart · PNG

LCTX total current assets history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Total Current Assets — Quarterly (USD)
Period ending	Total Current Assets (USD)
Jun 30, 2001	454,846
Mar 31, 2001	671,909
Dec 31, 2000	1,440,986
Sep 30, 2000	2,058,198
Jun 30, 2000	2,538,109
Mar 31, 2000	3,783,265
Dec 31, 1999	5,400,091
Sep 30, 1999	6,700,000
Jun 30, 1999	8,100,000
Mar 31, 1999	9,100,000
Sep 30, 1998	3,500,000
Jun 30, 1998	4,300,000
Mar 31, 1998	5,400,000
Dec 31, 1997	6,600,000
Sep 30, 1997	7,500,000
Jun 30, 1997	8,200,000
Mar 31, 1997	7,600,000
Dec 31, 1996	2,900,000
Sep 30, 1996	2,400,000
Jun 30, 1996	2,900,000
Sep 30, 1995	2,900,000
Jun 30, 1995	3,500,000
Mar 31, 1995	4,000,000
Dec 31, 1994	5,800,000
Sep 30, 1994	5,400,000
Jun 30, 1994	5,800,000
Mar 31, 1994	6,400,000
Dec 31, 1993	2,700,000
Sep 30, 1993	3,500,000
Jun 30, 1993	3,500,000
Mar 31, 1993	3,800,000
Dec 31, 1992	4,100,000
Sep 30, 1992	4,400,000
Jun 30, 1992	4,800,000
Mar 31, 1992	5,200,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.